News on EPO from BioPortfolio.com http://www.BioPortfolio.com Consolidated EPO news from BioPortfolio.com Wed, 10 Feb 2010 08:04:44 GMT en Stem Cell Research - Data on stem cell research discussed by researchers at Mersin University, Medical Departmhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026496&HITNO=0&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EPO&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026496&THISHREF=http://c.moreover.com/click/here.pl%3fz2530921857%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026496&HITNO=0&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EPO&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026496&THISHREF=http://c.moreover.com/click/here.pl%3fz2530921857%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Samples, please: Athletes face testing flurry in days before Olympics kick offhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026492&HITNO=1&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EPO&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026492&THISHREF=http://c.moreover.com/click/here.pl%3fz2530921135%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026492&HITNO=1&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EPO&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026492&THISHREF=http://c.moreover.com/click/here.pl%3fz2530921135%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comResearch & Development: Athletes and coaches might be tempted to try using the already readily available tools of gene therapy to booshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024974&HITNO=2&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EPO&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024974&THISHREF=http://c.moreover.com/click/here.pl%3fz2529316396%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024974&HITNO=2&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EPO&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024974&THISHREF=http://c.moreover.com/click/here.pl%3fz2529316396%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCBC: Lipoxen H2 revenue hit by EPO and Insulin delays, foresees positive news flow in 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019511&HITNO=3&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EPO&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019511&THISHREF=http://c.moreover.com/click/here.pl%3fz2526341893%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019511&HITNO=3&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EPO&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019511&THISHREF=http://c.moreover.com/click/here.pl%3fz2526341893%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comProactive Investors.co.uk: BioMimetic Therapeutics, Inc. Patent Portfolio Further Strengthenedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019331&HITNO=4&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EPO&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019331&THISHREF=http://c.moreover.com/click/here.pl%3fz2526231114%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019331&HITNO=4&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EPO&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019331&THISHREF=http://c.moreover.com/click/here.pl%3fz2526231114%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Geneticists Are On the Lookout for the First Gene-Doping Athleteshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023314&HITNO=5&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EPO&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023314&THISHREF=http://c.moreover.com/click/here.pl%3fz2528157304%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023314&HITNO=5&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EPO&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023314&THISHREF=http://c.moreover.com/click/here.pl%3fz2528157304%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDiscover Magazine: Lipoxen PLC : Trading and Programme Updatehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019204&HITNO=6&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EPO&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019204&THISHREF=http://c.moreover.com/click/here.pl%3fz2526177077%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019204&HITNO=6&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EPO&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019204&THISHREF=http://c.moreover.com/click/here.pl%3fz2526177077%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInvestegate: Gene doping risky for athleteshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016215&HITNO=7&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EPO&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016215&THISHREF=http://c.moreover.com/click/here.pl%3fz2524675006%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016215&HITNO=7&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EPO&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016215&THISHREF=http://c.moreover.com/click/here.pl%3fz2524675006%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCBC: Gene doping risky for athleteshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016115&HITNO=8&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EPO&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016115&THISHREF=http://c.moreover.com/click/here.pl%3fz2524646073%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016115&HITNO=8&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EPO&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016115&THISHREF=http://c.moreover.com/click/here.pl%3fz2524646073%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCanadian Broadcasting Corporation: EPO to grant patent notice to BioMimetic Therapeuticshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3996135&HITNO=9&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EPO&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3996135&THISHREF=http://c.moreover.com/click/here.pl%3fz2516128651%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3996135&HITNO=9&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EPO&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3996135&THISHREF=http://c.moreover.com/click/here.pl%3fz2516128651%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: BioMimetic Therapeutics, Inc. Patent Portfolio Further Strengthenedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3996617&HITNO=10&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EPO&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3996617&THISHREF=http://c.moreover.com/click/here.pl%3fz2516387867%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3996617&HITNO=10&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EPO&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3996617&THISHREF=http://c.moreover.com/click/here.pl%3fz2516387867%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: BioMimetic Therapeutics, Inc. Patent Portfolio Further Strengthenedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3995401&HITNO=11&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EPO&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3995401&THISHREF=http://c.moreover.com/click/here.pl%3fz2515645583%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3995401&HITNO=11&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EPO&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3995401&THISHREF=http://c.moreover.com/click/here.pl%3fz2515645583%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Cytheris Announces Notice of Allowance for U.S. Patent Covering the Preparation and Uses of Its Glycosylated Rhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4000019&HITNO=12&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EPO&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4000019&THISHREF=http://c.moreover.com/click/here.pl%3fz2517787832%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4000019&HITNO=12&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EPO&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4000019&THISHREF=http://c.moreover.com/click/here.pl%3fz2517787832%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Cytheris Announces Notice of Allowance for U.S. Patent Covering the Preparation and Uses of its Glycosylated Rhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3998060&HITNO=13&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EPO&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3998060&THISHREF=http://c.moreover.com/click/here.pl%3fz2516938605%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3998060&HITNO=13&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EPO&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3998060&THISHREF=http://c.moreover.com/click/here.pl%3fz2516938605%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Cytheris Announces Notice of Allowance for U.S. Patent Covering the Preparation and Uses of its Glycosylated Rhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3997931&HITNO=14&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EPO&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3997931&THISHREF=http://c.moreover.com/click/here.pl%3fz2516893783%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3997931&HITNO=14&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EPO&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3997931&THISHREF=http://c.moreover.com/click/here.pl%3fz2516893783%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: